A randomized single-blind pilot study of compensatory strategies in schizophrenia outpatients

被引:68
作者
Velligan, DI
Prihoda, TJ
Ritch, JL
Maples, N
Bow-Thomas, CC
Dassori, A
机构
[1] Univ Texas, Hlth Sci Ctr, Dept Psychiat, Div Schizophrenia & Related Disorders, San Antonio, TX 78229 USA
[2] San Antonio State Hosp, Clin Res Unit, San Antonio, TX USA
[3] Univ Texas, Hlth Sci Ctr, Dept Psychiat & Pathol, San Antonio, TX 78285 USA
[4] Univ Texas, Hlth Sci Ctr, Dept Psychiat, San Antonio, TX 78284 USA
[5] San Antonio State Hosp, Clin Res Unit, San Antonio, TX USA
[6] Univ Texas, Hlth Sci Ctr, Dept Psychiat, San Antonio, TX USA
[7] San Antonio State Hosp, Clin Res Unit, San Antonio, TX USA
[8] San Antonio State Hosp, Clin Res Unit, San Antonio, TX USA
[9] Univ Texas, Hlth Sci Ctr, Dept Psychiat, Div Schizophrenia & Related Disorders, San Antonio, TX 78229 USA
[10] San Antonio State Hosp, Clin Res Unit, San Antonio, TX USA
关键词
schizophrenia; cognitive deficits; compensatory strategies; environmental supports; psychosocial treatment;
D O I
10.1093/oxfordjournals.schbul.a006938
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
In a previous study, we found that cognitive adaptation training (CAT)-a manual-driven program of environmental supports designed to bypass cognitive deficits-improved multiple domains of outcome in schizophrenia patients recently discharged from a State psychiatric facility. The present study examined the efficacy of CAT in a sample of patients who had been in the community at least 3 months. Forty-five medicated schizophrenia patients were randomly assigned for 9 months to one of three conditions: (1) CAT, (2) a condition that controlled for therapist time and provided environmental changes unrelated to cognitive deficits, or (3) followup only. Comprehensive assessments were conducted every 3 months by blinded raters. Results of repeated measures analyses of covariance for mixed models indicated that patients participating in CAT had better adaptive function and quality of life, and fewer positive symptoms than those in the two non-CAT conditions. Results indicate that compensatory strategies may improve various outcomes in schizophrenia outpatients.
引用
收藏
页码:283 / 292
页数:10
相关论文
共 50 条
  • [31] Effects of add-on mirtazapine on neurocognition in schizophrenia: a double-blind, randomized, placebo-controlled study
    Stenberg, Jan-Henry
    Terevnikov, Viatcheslav
    Joffe, Marina
    Tiihonen, Jari
    Tchoukhine, Evgueni
    Burkin, Mark
    Joffe, Grigori
    [J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2010, 13 (04) : 433 - 441
  • [32] Risperidone versus clozapine in treatment-resistant schizophrenia:: A randomized pilot study
    Wahlbeck, K
    Cheine, M
    Tuisku, K
    Ahokas, A
    Joffe, G
    Rimón, R
    [J]. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2000, 24 (06) : 911 - 922
  • [33] Auricular Acupressure Improve Constipation of Patients With Schizophrenia: A Pilot Randomized Controlled Study
    Gong, Ciao-Min
    Huang, Hui-Chuan
    Liu, Ju-Han
    Yu, Shiou-Shiun
    Chen, Yu-Ting
    [J]. BIOLOGICAL RESEARCH FOR NURSING, 2024, 26 (03) : 418 - 428
  • [34] Effects of adjunctive intranasal oxytocin on olfactory identification and clinical symptoms in schizophrenia: Results from a randomized double blind placebo controlled pilot study
    Lee, Mary R.
    Wehring, Heidi J.
    McMahon, Robert P.
    Linthicum, Jared
    Cascella, Nicola
    Liu, Fang
    Bellack, Alan
    Buchanan, Robert W.
    Strauss, Gregory P.
    Contoreggi, Carlo
    Kelly, Deanna L.
    [J]. SCHIZOPHRENIA RESEARCH, 2013, 145 (1-3) : 110 - 115
  • [35] Effects of the Cannabinoid-1 Receptor Antagonist Rimonabant on Psychiatric Symptoms in Overweight People With Schizophrenia A Randomized, Double-Blind, Pilot Study
    Kelly, Deanna L.
    Gorelick, David A.
    Conley, Robert R.
    Boggs, Douglas L.
    Linthicum, Jared
    Liu, Fang
    Feldman, Stephanie
    Ball, M. Patricia
    Wehring, Heidi J.
    McMahon, Robert P.
    Huestis, Marilyn A.
    Heishman, Stephen J.
    Warren, Kimberly R.
    Buchanan, Robert W.
    [J]. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2011, 31 (01) : 86 - 91
  • [36] L-lysine as adjunctive treatment in patients with schizophrenia: a single-blinded, randomized, cross-over pilot study
    Caroline Wass
    Daniel Klamer
    Evangelos Katsarogiannis
    Erik Pålsson
    Lennart Svensson
    Kim Fejgin
    Inga-Britt Bogren
    Jörgen A Engel
    Birgitta Rembeck
    [J]. BMC Medicine, 9
  • [37] Efficacy of Integrated Social Cognitive Remediation vs. Neurocognitive Remediation in Improving Functional Outcome in Schizophrenia: Concept and Design of a Multicenter, Single-Blind RCT (The ISST Study)
    Woelwer, Wolfgang
    Frommann, Nicole
    Lowe, Agnes
    Kamp, Daniel
    Weide, Karolin
    Bechdolf, Andreas
    Brockhaus-Dumke, Anke
    Hurlemann, Rene
    Muthesius, Ana
    Klingberg, Stefan
    Hellmich, Martin
    Schmied, Sabine
    Meyer-Lindenberg, Andreas
    [J]. FRONTIERS IN PSYCHIATRY, 2022, 13
  • [38] The Momentum trial: the efficacy of using a smartphone application to promote patient activation and support shared decision making in people with a diagnosis of schizophrenia in outpatient treatment settings: a randomized controlled single-blind trial
    Vitger, Tobias
    Austin, Stephen F.
    Petersen, Lone
    Tonder, Esben S.
    Nordentoft, Merete
    Korsbek, Lisa
    [J]. BMC PSYCHIATRY, 2019, 19 (1)
  • [39] Virtual reality therapy targeting ideas of reference in patients with psychosis: a single-blind parallel-group randomized controlled trial
    Jeon, Eunjin
    Li, Ling
    Le, Thi-Hung
    Kim, Woo-Sung
    Odkhuu, Soyolsaikhan
    Kang, Chae Yeong
    Setiani, Ariana
    Rami, Fatima Zahra
    Chung, Young-Chul
    [J]. PSYCHOLOGICAL MEDICINE, 2025, 55
  • [40] Cognitive training of self-initiation of semantic encoding strategies in schizophrenia: A pilot study
    Guimond, Synthia
    Lepage, Martin
    [J]. NEUROPSYCHOLOGICAL REHABILITATION, 2016, 26 (03) : 464 - 479